SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-15-070120
Filing Date
2015-10-09
Accepted
2015-10-09 15:50:32
Documents
7
Period of Report
2015-10-09

Document Format Files

Seq Description Document Type Size
1 6-K a15-20967_16k.htm 6-K 20708
2 EX-99.1 a15-20967_1ex99d1.htm EX-99.1 19195
3 EX-99.2 a15-20967_1ex99d2.htm EX-99.2 10662
4 EX-99.3 a15-20967_1ex99d3.htm EX-99.3 27120
5 GRAPHIC g209671moi001.jpg GRAPHIC 5112
6 GRAPHIC g209671mqi001.jpg GRAPHIC 5112
7 GRAPHIC g209671mmi001.jpg GRAPHIC 5112
  Complete submission text file 0001104659-15-070120.txt   100407
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37368 | Film No.: 151153126
SIC: 2836 Biological Products, (No Diagnostic Substances)